Join the Basal Cell Carcinoma group to help and get support from people like you.
Basal Cell Carcinoma News
Related terms: Basal Cell Skin Cancer, Cancer, Basal Cell Carcinoma, Rodent Ulcer, Skin Cancer, Basal Cell, BCC
Teledermoscopy Accurate for Detecting Skin Cancers
WEDNESDAY, Nov. 20, 2024 – Teledermoscopy has high accuracy for detecting skin cancers, according to a research letter published online Nov. 9 in the Journal of the American Academy of Dermatology....
New Set of Risk Factors Can Boost Detection of Suspicious Skin Lesions
MONDAY, Nov. 4, 2024 – A new set of skin cancer risk factors can improve detection of suspicious skin lesions, according to a study published online Sept. 6 in Scientific Reports. Shafiqul Islam,...
Prevalence of Skin Cancer Varies for Sexual Minority, Heterosexual Adults
FRIDAY, July 19, 2024 – With respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females, according to a study...
Have Fun in the Sun, But Protect Your Skin, Expert Says
SUNDAY, July 14, 2024 — Roughly 20% of Americans are diagnosed with skin cancer at some point in their lives, but it's not inevitable. Skin cancer is not only the most common cancer, it's also the m...
Rural Residents Continue to Have Higher Odds of Skin Cancer
TUESDAY, July 9, 2024 – Urban-rural disparities in skin cancer prevalence continue to persist, according to a study published in the June issue of the Journal of Drugs in Dermatology. Rachel R. Lin, ...
Few Patients With Positive Margins After Basal Cell Excision Have Recurrence
MONDAY, July 1, 2024 – Among patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic margins have clinical recurrence, according to a study...
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma
WEDNESDAY, June 5, 2024 – Neoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among patients with resectable,...
Non-Hispanic Black Melanoma Patients Present With Advanced Disease
WEDNESDAY, May 15, 2024 – Non-Hispanic Black (NHB) melanoma patients have distinct tumor characteristics, presenting with more advanced disease and exhibiting worse outcomes, according to a study...
Outdoor Workers Face Skin Cancer Danger
FRIDAY, May 10, 2024 – Steve Murray, 68, has spent a lot of time out in the sun, at work and at play. Murray worked construction for several decades, and as a child spent summers on the beach in...
'Virtual Biopsy' Tests Skin Lesions Without a Scalpel
FRIDAY, April 12, 2024 – Folks with a suspicious-looking mole or questionable skin lesion often have to endure a scalpel or shaver so their doctor can cut off a sample to send in for biopsy. But a...
Military Service Can Bring Melanoma Danger
TUESDAY, March 12, 2024 — U.S. military veterans, especially those who served in the Air Force, are at high risk for one of the deadliest skin cancers, melanoma. The risk owes to work hazards a...
Sarah Ferguson Diagnosed With Skin Cancer
MONDAY, Jan. 22, 2024 (HealthDay New) – Sarah Ferguson, the Duchess of York, announced Monday that she has been diagnosed with melanoma, an aggressive form of skin cancer. "I have been taking some...
FDA Approves AI Device That Helps Spot Skin Cancer
THURSDAY, Jan. 18, 2024 (HealthDay news) – The first medical device powered by artificial intelligence and designed to help doctors catch skin cancer has been approved by the U.S. Food and Drug...
FDA Approves Libtayo (cemiplimab-rwlc) as First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma
TARRYTOWN, N.Y. and PARIS, Feb. 9, 2021 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) approved the PD-1 ...
FDA Approves Odomzo (sonidegib) for Locally Advanced Basal Cell Carcinoma
July 24, 2015 – The U.S. Food and Drug Administration today approved Odomzo (sonidegib) to treat patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation...